Bravoxin 10 suspension for injection for cattle and sheep
Bravoxin 10 suspension for injection for cattle and sheep
Not authorised
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type B, beta toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium perfringens, type D, epsilon toxoid
- Clostridium chauvoei, Inactivated
- Clostridium novyi, toxoid
- Clostridium septicum, toxoid
- Tetanus toxoid adsorbed
- Clostridium sordellii, toxoid
- Clostridium novyi, type D, toxoid
Product identification
Medicine name:
Bravoxin 10 suspension for injection for cattle and sheep
Bravoxin 10 Suspensie voor injectie
Bravoxin 10 Suspension injectable
Bravoxin 10 Injektionssuspension
Active substance:
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type B, beta toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium perfringens, type D, epsilon toxoid
- Clostridium chauvoei, Inactivated
- Clostridium novyi, toxoid
- Clostridium septicum, toxoid
- Tetanus toxoid adsorbed
- Clostridium sordellii, toxoid
- Clostridium novyi, type D, toxoid
Target species:
-
Cattle
-
Sheep
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Clostridium perfringens, type A, alpha toxoid0.50/enzyme-linked immunosorbent assay unit1.00millilitre(s)
-
Clostridium perfringens, type B, beta toxoid18.20/international unit(s)1.00millilitre(s)
-
Clostridium perfringens, type C, beta toxoid18.20/international unit(s)1.00millilitre(s)
-
Clostridium perfringens, type D, epsilon toxoid5.30/international unit(s)1.00millilitre(s)
-
Clostridium chauvoei, Inactivated90.00/percentage protection1.00millilitre(s)
-
Clostridium novyi, toxoid3.80/international unit(s)1.00millilitre(s)
-
Clostridium septicum, toxoid4.60/international unit(s)1.00millilitre(s)
-
Tetanus toxoid adsorbed4.90/international unit(s)1.00millilitre(s)
-
Clostridium sordellii, toxoid4.40/international unit(s)1.00millilitre(s)
-
Clostridium novyi, type D, toxoid17.40/unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Milk0day
-
Meat and offal0day
-
-
Sheep
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AB01
- QI04AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Belgium
Package description:
- (ID1): 1 Box with 1 Bottle (Low Density PolyEthylene) with 20 millilitre(s) (20 millilitre(s))
- (ID2): 1 Box with 1 Bottle (Low Density PolyEthylene) with 50 millilitre(s) (50 millilitre(s))
- (ID3): 1 Box with 1 Bottle (Low Density PolyEthylene) with 100 millilitre(s) (100 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- MSD Animal Health UK Limited
- Intervet International B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V329576
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0279/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.